© 2025 CellCarta - All rights reserved.
Through deep collaboration with biopharma partners, we proactively create and validate innovative immunology assays that stay ahead of evolving scientific and clinical demands.
We embed regulatory strategy throughout assay development, engaging directly with agencies such as the FDA to define sensitivity thresholds, biomarker strategies, and standards for immune cell populations
Immune monitoring decisions shape the trajectory of your clinical program. Misaligned biomarkers, insufficient assay sensitivity, or cross-site variability can delay timelines and compromise confidence in your data.
We bring scientific and regulatory teams together from day one through submission, anticipating challenges early to keep your programs on track and on time.
Consistent, regulatory-ready data across regions, powered by fully owned labs that preserve both scientific control and local regulatory expertise.
Our immunology experts bring decades of experience to help you define what matters most: what to measure, when, and why, aligning biomarkers and assays to maximize clinical and therapeutic impact.
We deliver high-quality data with industry-leading consistency and timing, ensuring results are available when key development decisions are made.
Knowledge that allows us to anticipate and reduce risk
Dedicated Project Manager and Scientist for each project
Trusted by start-ups and & large pharma
Worldwide footprint: North America, Europe, China, Australia
Handling all assays: from complex to routine ones
Knowledge that allows us to anticipate and reduce risk
Dedicated PM and PS for each project
Trusted by start-ups and & large pharma
Worldwide footprint
Handling all assays: from complex to routine ones
Quality matters at every stage. With a specialist immunology CRO, the right biomarker strategy does more than generate data. It builds the kind of confidence that holds up in every submission, across every region, through every phase.
Quality starts with people. Our team of PhD-level scientists brings deep, hands-on expertise in flow cytometry and immunology, actively contributing to the scientific community through participation in worldwide conferences. By staying closely connected to the latest advancements, we ensure our approaches remain at the forefront of innovation while grounded in proven methodologies .
Built for reliability, our multi-site infrastructure provides true operational resilience. With established assay transfer capabilities and seamless cross-lab coordination, we maintain continuity even in the face of shifting timelines or unexpected disruptions. This means fewer delays, stronger data integrity, and a partner you can depend on to keep your studies on track.
Quality starts with people. Our team of PhD-level scientists brings deep, hands-on expertise in flow cytometry and immunology, actively contributing to the scientific community through participation in worldwide conferences. By staying closely connected to the latest advancements, we ensure our approaches remain at the forefront of innovation while grounded in proven methodologies .
Immune monitoring decisions shape the trajectory of your clinical program. Misaligned biomarkers, insufficient assay sensitivity, or cross-site variability can delay timelines and compromise confidence in your data.
Quality matters at every stage. With a specialist immunology CRO, the right biomarker strategy does more than generate data. It builds the kind of confidence that holds up in every submission, across every region, through every phase.
Through deep collaboration with biopharma partners, we proactively create and validate innovative immunology assays that stay ahead of evolving scientific and clinical demands.
We embed regulatory strategy throughout assay development, engaging directly with agencies such as the FDA to define sensitivity thresholds, biomarker strategies, and standards for immune cell populations.
Our immunology experts bring decades of experience to help you define what matters most: what to measure, when, and why, aligning biomarkers and assays to maximize clinical and therapeutic impact.
We bring scientific and regulatory teams together from day one through submission, anticipating challenges early to keep your programs on track and on time.
Consistent, regulatory-ready data across regions, powered by fully owned labs that preserve both scientific control and local regulatory expertise.
We deliver high-quality data with industry-leading consistency and timing, ensuring results are available when key development decisions are made.